Please use this identifier to cite or link to this item: https://doi.org/10.2217/pme.12.124
DC FieldValue
dc.titleWillingness-to-pay and preferences for warfarin pharmacogenetic testing in Chinese warfarin patients and the Chinese general public
dc.contributor.authorChan, S.L.
dc.contributor.authorWen Low, J.J.
dc.contributor.authorLim, Y.W.
dc.contributor.authorFinkelstein, E.
dc.contributor.authorFarooqui, M.A.
dc.contributor.authorChia, K.S.
dc.contributor.authorWee, H.L.
dc.date.accessioned2014-05-19T02:56:19Z
dc.date.available2014-05-19T02:56:19Z
dc.date.issued2013
dc.identifier.citationChan, S.L., Wen Low, J.J., Lim, Y.W., Finkelstein, E., Farooqui, M.A., Chia, K.S., Wee, H.L. (2013). Willingness-to-pay and preferences for warfarin pharmacogenetic testing in Chinese warfarin patients and the Chinese general public. Personalized Medicine 10 (2) : 127-137. ScholarBank@NUS Repository. https://doi.org/10.2217/pme.12.124
dc.identifier.issn17410541
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/53260
dc.description.abstractAim: Genetic factors have been found to affect warfarin maintenance dose and a key factor for the successful clinical implementation of warfarin pharmacogenetic testing (WPGT) is economic sustainability. We aimed to estimate the willingness-to-pay (WTP) and preferences for WPGT in Singaporean Chinese subjects. Methods & subjects: A total of 197 warfarin patients and 187 members of the public completed a questionnaire. The discrete choice methodology was used and the choice model was estimated using hierarchical Bayes. Marginal WTP, attribute importance and WTP for three hypothetical WPGTs were calculated from the estimated utilities. Results: Both patients and the public placed most emphasis on side effects, followed by cost, number of International Normalized Ratio tests and 'nature of test. WTP for WPGT ranged from S160 to S730. Conclusion: WPGTs are likely to be economically sustainable. © 2013 Future Medicine Ltd.
dc.description.urihttp://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.2217/pme.12.124
dc.sourceScopus
dc.subjectAsian
dc.subjectdiscrete choice experiment
dc.subjectpharmacogenetic testing
dc.subjectwarfarin
dc.subjectwillingness-to-pay
dc.typeArticle
dc.contributor.departmentSAW SWEE HOCK SCHOOL OF PUBLIC HEALTH
dc.contributor.departmentPHARMACY
dc.description.doi10.2217/pme.12.124
dc.description.sourcetitlePersonalized Medicine
dc.description.volume10
dc.description.issue2
dc.description.page127-137
dc.identifier.isiut000316040800008
Appears in Collections:Staff Publications

Show simple item record
Files in This Item:
There are no files associated with this item.

Page view(s)

102
checked on Feb 18, 2020

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.